Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The present study reports the results of an open-label trial on the use of the combination of olanzapine (an atypical antipsychotic) serotonin reuptake inhibitors (SRIs) in 26 resistant outpatients affected by resistant obsessive-compulsive disorder (OCD). All patients had been suffering from OCD, according to DSM IV criteria, for at least 2 years and had different comorbid disorders; they had been treated with an SRI at adequate dosages for at least 6 months, or had tried different augmentation strategies with no or poor response. As a result, olanzapine was added and continued for 1 year. After 12 weeks of this regimen, most of the patients (17) had shown a reduction in OC symptoms, as assessed by a decrease in the Yale-Brown Obsessive Compulsive Scale total score, which continued throughout subsequent months. Only mild side-effects were recorded and no patient halted the treatment. The addition of olanzapine would appear to be a useful short- and long-term strategy for augmenting SRI effectiveness in resistant OCD patients, especially in those presenting comorbidity with bipolar disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The CANMAT Task Force 2012 report included several small case reports indicating the potential benefit of lithium,743 anticonvulsants,743, 746 olanzapine,747, 748 risperidone,749, 750 quetiapine751 and aripiprazole 752 for the treatment of comorbid OCD (all level 4 evidence).”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2022) · doi:10.1176/appi.books.9780890425787 · Cited by 23,476
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
ECDEU Assessment Manual: (591322011-001)
Guy, W. (1976) · PsycEXTRA Dataset · doi:10.1037/e591322011-001 · Cited by 1,896
Assessment of insight in psychosis
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.873 · Cited by 1,095
Bystritsky, A., Ackerman, D. L., Rosen, R. M., Vapnik, T., Gorbis, E., Maidment, K. M., & Saxena, S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0418 · Cited by 220
Shapira, N. A., Ward, H. E., MANDOKI, M. W., Murphy, T. K., Yang, M. C. K., Blier, P., & Goodman, W. K. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.010 · Cited by 154
Atmaca, M., Kuloglu, M., Tezcan, E., & Gecici, O. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200205000-00004 · Cited by 149
Antidepressant discontinuation: a review of the literature.
Lejoyeux, M., & Adès, J. (1997) · PubMed · Cited by 148
Research works printed but not linked: 6
- Amador X F, 1994, Am J Psychiatry, 150, 873
- 10.3109/9780203212899 · doi:10.3109/9780203212899
- First M B, 1997, Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition
- McDougle C J, 1997, J Clin Psychiatry, 58, 11
- McDougle C J, 1994, J Clin Psychiatry, 55, 24
- Stein D J, 1992, J Clin Psychiatry, 53, 123
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Evidence-based pharmacotherapy of obsessive-compulsive disorder
Fineberg, N. A., Brown, A., Reghunandanan, S., & Pampaloni, I. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001829 · Cited by 336
Fineberg, N. A., Reghunandanan, S., Simpson, H. B., Phillips, K. A., Richter, M. A., Matthews, K., Stein, D. J., Sareen, J., Brown, A., & Sookman, D. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.003 · Cited by 150
“In randomized controlled OCD trials of SSRIs and clomipramine, improvements have been noted in obsessions and compulsions within 1 or 2 weeks after initiation (March et al., 1998; Riddle et al., 2001; Hollander et al., 2003b; reviewed in Fineberg et al. (2012)).”
BackgroundRole of dopamine in the pathophysiology and treatment of obsessive–compulsive disorder
Koo, M.-S., Kim, E.-J., Roh, D., & Kim, C.-H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.148 · Cited by 125
Metadata
- Authors
- Marazziti, D., Pfanner, C., Dell’osso, B., Ciapparelli, A., Presta, S., Corretti, G., Di Nasso, E., Mungai, F., & Dell’osso, L.
- Affiliations
- University of Pisa (IT)
- Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Pisa, Italy.
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2005-07
- Volume
- 19
- Issue
- 4
- Pages
- 392-394
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2089496191
- Cited by
- 56
- References
- 20
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 2 · 2020: 1 · 2019: 4 · 2018: 2 · 2016: 3 · 2015: 5 · 2014: 2 · 2013: 1 · 2012: 5
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- olanzapine, treatment-resistant OCD, augmentation strategies, serotonin reuptake inhibitors, atypical antipsychotics, bipolar disorder comorbidity, Yale-Brown Obsessive Compulsive Scale, adverse effects
- MeSH terms
- Olanzapine, Adult, Benzodiazepines, Bipolar Disorder, Drug Resistance, Female, Humans, Italy, Long-Term Care, Male, Obsessive-Compulsive Disorder, Psychiatric Status Rating Scales, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. https://app.cochat.ai/papers/10.1177/0269881105053299
- The paper
- Marazziti, D., Pfanner, C., Dell’osso, B., Ciapparelli, A., Presta, S., Corretti, G., Di Nasso, E., Mungai, F., & Dell’osso, L. (2005). Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. Journal of Psychopharmacology. https://doi.org/10.1177/0269881105053299
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.